ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
US Tech 100
18,488.00
-0.25%
Dow Jones
38,798.99
-0.22%
Brent Oil
79.395
0.00%
Bitcoin
69,402.38
0.10%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Orgenesis Inc (ORGS)

  7. Orgenesis Inc (ORGS) News

ORGS

Orgenesis (ORGS)

Orgenesis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORGS
DateTimeSourceHeadlineSymbolCompany
06/06/20244:05PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ORGSOrgenesis Inc
06/04/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ORGSOrgenesis Inc
05/31/20246:14AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
05/24/20249:16AMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:ORGSOrgenesis Inc
05/23/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
05/21/20247:00AMGlobeNewswire Inc.Orgenesis Provides Business Update for the First Quarter of 2024NASDAQ:ORGSOrgenesis Inc
05/20/20244:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGSOrgenesis Inc
05/15/20244:01PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ORGSOrgenesis Inc
05/06/20243:30PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ORGSOrgenesis Inc
05/06/20243:28PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ORGSOrgenesis Inc
05/06/20243:26PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ORGSOrgenesis Inc
04/15/20245:07PMGlobeNewswire Inc.Orgenesis Provides Year End Business UpdateNASDAQ:ORGSOrgenesis Inc
04/10/202412:00PMGlobeNewswire Inc.Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global AccessibilityNASDAQ:ORGSOrgenesis Inc
03/18/20248:30AMGlobeNewswire Inc.Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe ConferenceNASDAQ:ORGSOrgenesis Inc
03/13/20248:30AMGlobeNewswire Inc.Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic ExosomesNASDAQ:ORGSOrgenesis Inc
03/04/20248:30AMGlobeNewswire Inc.Orgenesis Inc. Announces $2.3 Million Private PlacementNASDAQ:ORGSOrgenesis Inc
02/29/20248:30AMGlobeNewswire Inc.Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP ManufacturingNASDAQ:ORGSOrgenesis Inc
01/31/20249:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
01/31/20249:15AMGlobeNewswire Inc.Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to ClinicNASDAQ:ORGSOrgenesis Inc
01/24/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
01/22/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
01/08/20245:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGSOrgenesis Inc
01/08/20245:36PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ORGSOrgenesis Inc
01/05/20246:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
11/14/20238:30AMGlobeNewswire Inc.Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TMNASDAQ:ORGSOrgenesis Inc
11/13/20234:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGSOrgenesis Inc
11/13/20234:15PMGlobeNewswire Inc.Orgenesis Provides Business Update for the Third Quarter of 2023NASDAQ:ORGSOrgenesis Inc
11/09/20237:41AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ORGSOrgenesis Inc
11/08/20239:24AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGSOrgenesis Inc
11/08/20239:00AMGlobeNewswire Inc.Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct OfferingNASDAQ:ORGSOrgenesis Inc
 Showing the most relevant articles for your search:NASDAQ:ORGS

Your Recent History

NYSE
MGNX
NYSE
SEE
Sealed Air
BIT
UC2V7K
Unicredit Bank
USOTC
AVVIY
Aviva (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved